Ocular disease leads to decreased concentrations of epidermal growth factor in the tear fluid.

The concentration of epidermal growth factor (EGF) in tear fluid (TF) was recently shown to decrease with increasing tear fluid flow (TFF). The purpose of the present study was to clarify the effects of ocular surface disease on the TF EGF concentrations. Tear fluid samples (n = 243) were collected from diseased eyes by means of blunted glass capillaries. The time of collection was measured for each sample, and the tear fluid flow in the capillaries (TFFc) was calculated. The concentration of human EGF (hEGF) was determined using a time-resolved immunofluorometric assay (TR-IFMA). For statistical analysis diagnosis-dependent multigrouping was performed and the data of the patient groups were compared to the data for a control group. The control material consisted of 271 TF samples collected from healthy eyes before (n = 59) and after stimulation of reflex tearing (n = 212). It was shown that TF specimens of patients (n = 243) contained significantly (p less than 0.001) less EGF (mean 952 pg/ml) than the TF of healthy control individuals before (n = 59 samples; mean 6589 pg/ml) or after stimulation of reflex tearing (n = 212 samples; mean 2762 pg/ml). The EGF concentration of every patient group was significantly lower than that found in the TF of control individuals both before and during reflex tearing (p less than 0.001). The rate of EGF released with TF during collection did not differ significantly between the various groups of patients or from that released with the TF of normal individuals before induction of reflex tearing.(ABSTRACT TRUNCATED AT 250 WORDS)

[1]  S Kinoshita,et al.  Presence of epidermal growth factor in human tears. , 1989, Investigative ophthalmology & visual science.

[2]  G. Schultz,et al.  Growth Factors and Corneal Epithelium , 1988, Cornea.

[3]  T. Hayashi,et al.  Radioimmunoassay of human epidermal growth factor--hEGF levels in human body fluids. , 1988, Journal of pharmacobio-dynamics.

[4]  P. Fagerholm,et al.  Human Epidermal Growth Factor—the influence on the healing of surgically closed corneal wounds , 1987, Acta ophthalmologica. Supplement.

[5]  M. Nicolson,et al.  Size heterogeneity of epidermal growth factor in human body fluids. , 1987, Life sciences.

[6]  U. Stenman,et al.  An ultrasensitive time-resolved immunofluorometric assay of human epidermal growth factor. , 1986, Analytical biochemistry.

[7]  K. Chan Release of plasminogen activator by cultured corneal epithelial cells during differentiation and wound closure. , 1986, Experimental eye research.

[8]  B. Damato,et al.  Senile atrophy of the human lacrimal gland: the contribution of chronic inflammatory disease. , 1984, The British journal of ophthalmology.

[9]  S. Cohen,et al.  Proliferation of corneal epithelium induced by epidermal growth factor. , 1973, Experimental eye research.

[10]  G. Setten Epidermal growth factor in human tear fluid: increased release but decreased concentrations during reflex tearing. , 1990 .

[11]  N. Burstein Growth factor effects on corneal wound healing. , 1987, Journal of ocular pharmacology.

[12]  P. Barr,et al.  Biosynthetic human EGF accelerates healing of Neodecadron-treated primate corneas. , 1985, Investigative ophthalmology & visual science.

[13]  G. Schultz,et al.  Effect of growth factors with dexamethasone on healing of rabbit corneal stromal incisions. , 1985, Experimental eye research.

[14]  M. Das,et al.  Epidermal growth factor: mechanisms of action. , 1982, International review of cytology.